Breast Cancer | Oncology Today with Dr Neil Love: Immune Checkpoint Inhibition in Breast Cancer

published 1 month ago by Dr Neil Love

Featuring a discussion on recent data on the use of immune checkpoint inhibition in breast cancer with Dr Sylvia Adams, including the following topics: Immune Checkpoint Inhibition in Breast Cancer — Sylvia Adams, MD (0:00) Case: A woman in her mid-30s with de novo PD-L1-positive metastatic triple-negative breast cancer (mTNBC) receives atezolizumab/nab paclitaxel (24:50) Case: A woman in her early 40s with mTNBC develops immune-related autoimmune diabetes while undergoing treatment with atezolizumab/nab paclitaxel (30:51) Case: A woman in her early 30s with mTNBC and pseudoprogression on first-line atezolizumab/nab paclitaxel (39:22) CME information and select publications

more episodes from Research To Practice | Oncology Videos